Monitoring high-sensitivity CRP (hsCRP) levels in the weeks following an acute coronary syndrome (ACS) appears useful in identifying the risk of a subsequent major adverse cardiac event or death. In a secondary analysis of the multinational VISTA-16 trial that involved 4257 ACS patients including some from Australian centres, hsCRP levels were measured at 1, 2, ...
Ischaemic heart disease
Serial hsCRP monitoring predicts recurrent events after ACS
By Mardi Chapman
14 Mar 2019